Clinical trial
Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma
NCT06340204 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma
- Lead sponsor
- Peking University People's Hospital
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- March 25, 2024
- Completion date
- December 25, 2026
- Enrollment
- 44 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
ewing sarcoma